Literature DB >> 29730634

Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis.

Renato Alberto Sinico1, Andrea Doria2, Gabriella Moroni3, Paolo Gilles Vercelloni1, Silvana Quaglini4, Mariele Gatto2, Davide Gianfreda5, Lucia Sacchi4, Francesca Raffiotta3, Margherita Zen2, Gloria Costantini2, Maria Letizia Urban5, Federico Pieruzzi1, Piergiorgio Messa3, Augusto Vaglio5.   

Abstract

OBJECTIVES: To evaluate changes in demographic, clinical and histological presentation, and prognosis of lupus nephritis (LN) over time. PATIENTS AND METHODS: We studied a multicentre cohort of 499 patients diagnosed with LN from 1970 to 2016. The 46-year follow-up was subdivided into three periods (P): P1 1970-1985, P2 1986-2001 and P3 2002-2016, and patients accordingly grouped based on the year of LN diagnosis. Predictors of patient and renal survival were investigated by univariate and multivariate proportional hazards Cox regression analyses. Survival curves were compared using the log-rank test.
RESULTS: A progressive increase in patient age at the time of LN diagnosis (p<0.0001) and a longer time between systemic lupus erythematosus onset and LN occurrence (p<0.0001) was observed from 1970 to 2016. During the same period, the frequency of renal insufficiency at the time of LN presentation progressively decreased (p<0.0001) and that of isolated urinary abnormalities increased (p<0.0001). No changes in histological class and activity index were observed, while chronicity index significantly decreased from 1970 to 2016 (p=0.023). Survival without end-stage renal disease (ESRD) was 87% in P1, 94% in P2% and 99% in P3 at 10 years, 80% in P1 and 90% in P2 at 20 years (p=0.0019). At multivariate analysis, male gender, arterial hypertension, absence of maintenance immunosuppressive therapy, increased serum creatinine, and high activity and chronicity index were independent predictors of ESRD.
CONCLUSIONS: Clinical presentation of LN has become less severe in the last years, leading to a better long-term renal survival. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  lupus nephritis; research outcomes; systemic lupus erythematosus; treatment

Mesh:

Substances:

Year:  2018        PMID: 29730634     DOI: 10.1136/annrheumdis-2017-212732

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Association of Bowman's capsule rupture with prognosis in patients with lupus nephritis.

Authors:  Tongyue Duan; Xuejing Zhu; Qing Zhao; Li Xiao; Liyu He; Hong Liu; Anqun Chen; Shaobin Duan; Shuguang Yuan; Chengyuan Tang; Fang Yuan; Jianling Zhu; Xiaoping Zhu; Meichu Cheng; Yinghong Liu; Yu Liu; Fuyou Liu; Lin Sun
Journal:  J Nephrol       Date:  2022-04-18       Impact factor: 3.902

Review 2.  Lupus Nephritis: Improving Treatment Options.

Authors:  Myrto Kostopoulou; Sofia Pitsigavdaki; George Bertsias
Journal:  Drugs       Date:  2022-04-29       Impact factor: 9.546

Review 3.  Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist.

Authors:  Katherine L Hull; Sherna F Adenwalla; Peter Topham; Matthew P Graham-Brown
Journal:  Clin Med (Lond)       Date:  2021-12-17       Impact factor: 2.659

4.  Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival.

Authors:  Gabriella Moroni; Giulia Porata; Francesca Raffiotta; Silvana Quaglini; Giulia Frontini; Lucia Sacchi; Valentina Binda; Marta Calatroni; Francesco Reggiani; Giovanni Banfi; Claudio Ponticelli
Journal:  Kidney360       Date:  2021-11-05

Review 5.  Lupus nephritis.

Authors:  Hans-Joachim Anders; Ramesh Saxena; Ming-Hui Zhao; Ioannis Parodis; Jane E Salmon; Chandra Mohan
Journal:  Nat Rev Dis Primers       Date:  2020-01-23       Impact factor: 52.329

Review 6.  Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy.

Authors:  Naomi I Maria; Anne Davidson
Journal:  Nat Rev Rheumatol       Date:  2020-03-19       Impact factor: 20.543

Review 7.  Lupus nephritis: challenges and progress.

Authors:  Anne Davidson; Cynthia Aranow; Meggan Mackay
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

Review 8.  New therapeutic strategies in systemic lupus erythematosus management.

Authors:  Mariele Gatto; Margherita Zen; Luca Iaccarino; Andrea Doria
Journal:  Nat Rev Rheumatol       Date:  2019-01       Impact factor: 20.543

9.  Corticosteroids are the major contributors to the risk for serious infections in autoimmune disorders with severe renal involvement.

Authors:  Bogdan Obrișcă; Alexandra Vornicu; Roxana Jurubiță; Camelia Achim; Raluca Bobeică; Andreea Andronesi; Bogdan Sorohan; Vlad Herlea; Alexandru Procop; Constantin Dina; Gener Ismail
Journal:  Clin Rheumatol       Date:  2021-02-17       Impact factor: 2.980

Review 10.  A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus.

Authors:  Xin Huang; Qing Zhang; Huilin Zhang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-22       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.